Cardiology

Top Story

DECIDE-LVAD: Decision-making tool improves patient LVAD decision quality

DECIDE-LVAD: Decision-making tool improves patient LVAD decision quality
November 21, 2017

Read the Perspective from J. Eduardo Rame, MD, MPhil

ANAHEIM, Calif. — A decision-support intervention was associated with improved decision quality among candidates for a left ventricular assist device, according to results from the DECIDE-LVAD trial.

Decision quality was defined as patient knowledge plus concordance between a patient’s stated values and preference on whether to receive an LVAD, Larry A. Allen, MD, MHS, medical director of advanced HF and associate professor of medicine, University of Colorado Anschutz Medical Campus, Aurora, said during a presentation at the American Heart Association Scientific Sessions.

In the Journals

Endoluminal bypass shows promise for PAD

November 21, 2017
In a small randomized controlled study, endoluminal bypass with heparin-bonded covered stents demonstrated several advantages over conventional femoropopliteal surgery…
Meeting News

Current guidelines underestimate statin eligibility after MI in young adults

November 21, 2017
ANAHEIM, Calif. — The majority of adults who present with MI at age 50 years or younger did not meet current guideline-based treatment thresholds for statin…
In the Journals Plus

2 studies underscore high CV risk in primary aldosteronism, despite treatment

November 21, 2017
Patients with primary aldosteronism have markedly increased risk for cardiovascular and cerebrovascular events, including stroke and coronary artery disease, compared…

ACP: Improving health care price transparency ‘vital’

November 21, 2017
Increasing access to meaningful information, including price, cost and quality data on health care services, can aid in efforts to improve health care price transparency…
More Headlines »
CME CNE CPE

Integrating New Options Into Guideline-Directed Management of Heart Failure with Reduced Ejection Fraction

This activity is supported by educational funding provided by Amgen, Novartis Pharmaceuticals Corporation and St. Jude Medical, Inc.

Heart failure (HF) is a chronic condition that requires long-term commitment on the part of the patient in adhering to…
More »
Video
Meeting News

VIDEO: Discussion on diabetes drugs, CV outcomes fruitful

July 17, 2017
More »
Resource Centers
American Heart Association Scientific Sessions

American Heart Association Scientific Sessions

Video
Meeting News

VIDEO: Past AMA president discusses importance of physicians advocating for patients

September 15, 2017
More »
Advertisement
Advertisement